<?xml version="1.0" encoding="UTF-8" standalone="yes"?><drugResultsOutput hits="10" offset="0" totalResults="5585"><SearchResults><Drug id="54734" name="buprenorphine (buccal, BEMA), BioDelivery/ Endo" lastModificationDate="2018-07-21T00:00:00Z" phaseHighest="Launched"><CompanyOriginator>BioDelivery Sciences International Inc</CompanyOriginator><CompaniesPrimary><Company>BioDelivery Sciences International Inc</Company><Company>Purdue Pharma Canada</Company></CompaniesPrimary><IndicationsPrimary><Indication>Pain</Indication></IndicationsPrimary><ActionsPrimary><Action>Opioid receptor kappa antagonist</Action><Action>Opioid receptor mu partial agonist</Action></ActionsPrimary><Technologies><Technology>Buccal formulation systemic</Technology><Technology>Oral formulation</Technology><Technology>Small molecule therapeutic</Technology><Technology>Transmucosal formulation</Technology></Technologies><Summary>in the US for chronic &lt;b&gt;pain&lt;/b&gt; management [ 1736486 ], [ 1736491 ]. The company was previously investigating BEMA buprenorphine for the potential treatment of dental &lt;b&gt;pain&lt;/b&gt;. In July 2009, a phase...phase II trial in dental &lt;b&gt;pain&lt;/b&gt; began [ 1049161 ]. In December 2009, data were reported [ 1064751 ]; however, no further development has been reported. BDSI has also developed a high-dose BEMA buprenorphine/naloxone combination for the treatment</Summary><CompaniesSecondary><Company>Endo Health Solutions Inc</Company><Company>Endo International plc</Company></CompaniesSecondary><IndicationsSecondary><Indication>Lower back pain</Indication></IndicationsSecondary><ActionsSecondary><Action>Analgesic</Action></ActionsSecondary><AddedDate>2006-01-09T00:00:00Z</AddedDate></Drug><Drug id="31134" name="fentanyl (buccal, BEMA), BioDelivery/Meda" lastModificationDate="2018-09-13T00:00:00Z" phaseHighest="Launched"><CompanyOriginator>TOLMAR Therapeutics Inc</CompanyOriginator><CompaniesPrimary><Company>BioDelivery Sciences International Inc</Company><Company>Meda AB</Company><Company>TTY Biopharm Co Ltd</Company></CompaniesPrimary><IndicationsPrimary><Indication>Cancer pain</Indication></IndicationsPrimary><ActionsPrimary><Action>Opioid receptor mu agonist</Action></ActionsPrimary><Technologies><Technology>Buccal formulation systemic</Technology><Technology>Oral formulation</Technology><Technology>Small molecule therapeutic</Technology></Technologies><Summary>In October 2009, Onsolis was launched in the US for breakthrough cancer &lt;b&gt;pain&lt;/b&gt; by Meda [ 1049208 ]. In March 2012, distribution of Onsolis was temporarily suspended in the US. By that time, production of Onsolis had been temporarily...other &lt;b&gt;pain&lt;/b&gt; settings was ongoing. In January 2008, BDSI and Meda were planning to develop the Onsolis for back &lt;b&gt;pain&lt;/b&gt;, neuropathic &lt;b&gt;pain&lt;/b&gt; and arthritis &lt;b&gt;pain&lt;/b&gt; [ 867327 ], and by March 2010, phase</Summary><CompaniesSecondary><Company>Alvogen Korea</Company><Company>Arius Pharmaceuticals Inc</Company><Company>Bausch Health Companies Inc</Company><Company>Collegium Pharmaceutical Inc</Company><Company>KunWha Pharmaceutical Co Ltd</Company><Company>Meda Valeant Pharma Australia Ltd</Company><Company>Meda Valeant Pharma Canada Ltd</Company><Company>TOLMAR Therapeutics Inc</Company><Company>Transmucosal Technologies Ltd</Company></CompaniesSecondary><IndicationsSecondary><Indication>Arthralgia</Indication><Indication>Back pain</Indication><Indication>Neuropathic pain</Indication></IndicationsSecondary><ActionsSecondary><Action>Analgesic</Action></ActionsSecondary><AddedDate>2000-10-17T00:00:00Z</AddedDate></Drug><Drug id="57516" name="oxycodone extended-release (oral, DETERx, chronic pain), Collegium Pharmaceuticals" lastModificationDate="2018-10-31T00:00:00Z" phaseHighest="Launched"><CompanyOriginator>Collegium Pharmaceutical Inc</CompanyOriginator><CompaniesPrimary><Company>Collegium Pharmaceutical Inc</Company></CompaniesPrimary><RegulatoryDesignations><RegulatoryDesignation>Fast Track</RegulatoryDesignation></RegulatoryDesignations><IndicationsPrimary><Indication>Pain</Indication></IndicationsPrimary><ActionsPrimary><Action>Opioid receptor agonist</Action></ActionsPrimary><Technologies><Technology>Capsule formulation</Technology><Technology>Oral formulation</Technology><Technology>Oral sustained release formulation</Technology><Technology>Small molecule therapeutic</Technology></Technologies><Summary> COL-003 (oxycodone DETERx; Xtampza ER), an abuse-deterrent, multiparticulate, tamper-resistant, sustained-release formulation of the opioid agonist oxycodone, based on its DETERx technology. The product is indicated in the US for the management of &lt;b&gt;pain&lt;/b&gt; severe enough to require daily round-the-clock long-term opioid treatment and for which alternative options are inadequate [ 1992568 ]. In December 2010, the company was seeking to outlicense the drug [ 1157608 ]. In June 2016, the drug was launched</Summary><ActionsSecondary><Action>Analgesic</Action></ActionsSecondary><AddedDate>2007-06-18T00:00:00Z</AddedDate></Drug><Drug id="44699" name="fentanyl (buccal systemic, pain), Kyowa Kirin/Kyowa" lastModificationDate="2018-09-13T00:00:00Z" phaseHighest="Launched"><CompanyOriginator>Orexo AB</CompanyOriginator><CompaniesPrimary><Company>Gedeon Richter Ltd</Company><Company>Hisamitsu Pharmaceutical Co Inc</Company><Company>Kyowa Hakko Kirin Co Ltd</Company><Company>Kyowa Kirin</Company><Company>Menarini Asia-Pacific</Company><Company>Neopharm Ltd</Company><Company>NovaMed Pharmaceuticals Inc</Company><Company>Paladin Labs Inc</Company><Company>Sentynl Therapeutics Inc</Company></CompaniesPrimary><IndicationsPrimary><Indication>Cancer pain</Indication></IndicationsPrimary><ActionsPrimary><Action>Opioid receptor mu agonist</Action></ActionsPrimary><Technologies><Technology>Buccal formulation systemic</Technology><Technology>Oral formulation</Technology><Technology>Orally disintegrating tablet</Technology><Technology>Small molecule therapeutic</Technology><Technology>Tablet formulation</Technology></Technologies><Summary>Abstral; Rapinyl; Lunaldin; OX-20; KW-2246; EN-3267). The product is indicated for the treatment of breakthrough &lt;b&gt;pain&lt;/b&gt; in patients aged 18 years or older already receiving and tolerant to opioid therapy for chronic cancer &lt;b&gt;pain&lt;/b&gt; [ 1682498 ], [ 1256687 ], [ 1752583 ]. The product was first launched for the treatment of breakthrough &lt;b&gt;pain&lt;/b&gt; in patients using opioid therapy for chronic cancer &lt;b&gt;pain&lt;/b&gt; in Sweden (as Abstral) in June 2008, with further European launches occurring throughout 2009 [ 1406898 ], [ 945351</Summary><CompaniesSecondary><Company>Endo Health Solutions Inc</Company><Company>Galena Biopharma Inc</Company><Company>Kyowa Hakko Kogyo Co Ltd</Company><Company>NewBridge Pharmaceuticals Ltd</Company><Company>Orexo AB</Company></CompaniesSecondary><ActionsSecondary><Action>Analgesic</Action></ActionsSecondary><AddedDate>2003-04-22T00:00:00Z</AddedDate></Drug><Drug id="55195" name="fentanyl (buccal transmucosal, OraVescent), Cephalon" lastModificationDate="2019-02-26T00:00:00Z" phaseHighest="Launched"><CompanyOriginator>CIMA Labs Inc</CompanyOriginator><CompaniesPrimary><Company>Cephalon Inc</Company><Company>H Lundbeck A/S</Company><Company>Orphan Australia</Company><Company>Taiho Pharmaceutical Co Ltd</Company><Company>Teikoku Seiyaku KK</Company><Company>Teva Pharmaceutical Industries Ltd</Company><Company>Teva-Handok</Company></CompaniesPrimary><IndicationsPrimary><Indication>Cancer pain</Indication></IndicationsPrimary><ActionsPrimary><Action>Opioid receptor mu agonist</Action></ActionsPrimary><Technologies><Technology>Buccal formulation systemic</Technology><Technology>Small molecule therapeutic</Technology><Technology>Transmucosal formulation</Technology></Technologies><Summary>cancer &lt;b&gt;pain&lt;/b&gt; [ 833829 ], [ 1445820 ], [ 1683104 ]. In October 2006, Fentora was launched for cancer &lt;b&gt;pain&lt;/b&gt; in the US, and in January 2009 it was launched as Effentora in Europe [ 738425 ], [ 778008 ], [ 996146...non-cancer &lt;b&gt;pain&lt;/b&gt; including neuropathic &lt;b&gt;pain&lt;/b&gt; and back &lt;b&gt;pain&lt;/b&gt;, asking the company to implement a risk management plan to provide a potential avenue for approval in this setting [ 943276 ]. No further development was reported for the</Summary><CompaniesSecondary><Company>BMP Sunstone Corp</Company><Company>CIMA Labs Inc</Company></CompaniesSecondary><IndicationsSecondary><Indication>Back pain</Indication><Indication>Neuropathic pain</Indication><Indication>Pain</Indication></IndicationsSecondary><ActionsSecondary><Action>Analgesic</Action></ActionsSecondary><AddedDate>2006-04-06T00:00:00Z</AddedDate></Drug><Drug id="58903" name="fentanyl (sublingual spray, pain), Insys Therapeutics" lastModificationDate="2018-10-04T00:00:00Z" phaseHighest="Launched"><CompanyOriginator>Insys Therapeutics Inc</CompanyOriginator><CompaniesPrimary><Company>Insys Therapeutics Inc</Company><Company>Lunatus</Company></CompaniesPrimary><IndicationsPrimary><Indication>Cancer pain</Indication><Indication>Pain</Indication></IndicationsPrimary><ActionsPrimary><Action>Opioid receptor mu agonist</Action></ActionsPrimary><Technologies><Technology>Aerosol formulation dermatological</Technology><Technology>Buccal formulation systemic</Technology><Technology>Dermatological formulation</Technology><Technology>Small molecule therapeutic</Technology><Technology>Transdermal formulation</Technology></Technologies><Summary>cancer &lt;b&gt;pain&lt;/b&gt; in the US [ 1274702 ]. By January 2015, the company had held a discussion with the FDA for potential additional indications [ 1625978 ]; in December 2016 a phase II trial began in patients with post-operative &lt;b&gt;pain&lt;/b&gt; [ 1929830... a phase III trial was planned in this setting, along with a phase III trial in acute &lt;b&gt;pain&lt;/b&gt; [ 1929833 ]. A phase I trial in opioid-naive patients was initiated in January 2016 [ 1929829 ].</Summary><ActionsSecondary><Action>Analgesic</Action></ActionsSecondary><AddedDate>2007-12-10T00:00:00Z</AddedDate></Drug><Drug id="58143" name="PL-37" lastModificationDate="2019-03-05T00:00:00Z" phaseHighest="Phase 2 Clinical"><CompanyOriginator>Pharmaleads</CompanyOriginator><CompaniesPrimary><Company>Pharmaleads</Company></CompaniesPrimary><IndicationsPrimary><Indication>Neuropathic pain</Indication></IndicationsPrimary><ActionsPrimary><Action>Aminopeptidase N inhibitor</Action><Action>Neutral endopeptidase inhibitor</Action></ActionsPrimary><Technologies><Technology>Oral formulation</Technology><Technology>Small molecule therapeutic</Technology></Technologies><Summary> inhibitor (DENKI) with two active metabolites (PL-800 and PL-804) that targets both aminopeptidase N (APN) and neutral endopeptidase (NEP), for the potential oral treatment of chronic &lt;b&gt;pain&lt;/b&gt; conditions, particularly neuropathic &lt;b&gt;pain&lt;/b&gt; [ 831634 ], [ 963825 ], [ 1084806 ], [ 1889877 ] and surgical or post-traumatic &lt;b&gt;pain&lt;/b&gt; [ 2125154 ]. In April 2015, a phase II diabetic neuropathy trial was initiated in the UK [ 1653536 ]; in September 2015, the trial was initiated in France [ 1698326 ]; in November 2015,</Summary><CompaniesSecondary><Company>Debiopharm SA</Company></CompaniesSecondary><IndicationsSecondary><Indication>Pain</Indication></IndicationsSecondary><ActionsSecondary><Action>Analgesic</Action></ActionsSecondary><AddedDate>2007-09-19T00:00:00Z</AddedDate></Drug><Drug id="65347" name="NKTR-181" lastModificationDate="2019-05-30T00:00:00Z" phaseHighest="Pre-registration"><CompanyOriginator>Nektar Therapeutics</CompanyOriginator><CompaniesPrimary><Company>Inheris Biopharma Inc</Company><Company>Nektar Therapeutics</Company></CompaniesPrimary><RegulatoryDesignations><RegulatoryDesignation>Fast Track</RegulatoryDesignation></RegulatoryDesignations><IndicationsPrimary><Indication>Lower back pain</Indication></IndicationsPrimary><ActionsPrimary><Action>Opioid receptor mu agonist</Action></ActionsPrimary><Technologies><Technology>Oral formulation</Technology><Technology>Oral sustained release formulation</Technology><Technology>PEGylated formulation</Technology><Technology>Small molecule therapeutic</Technology><Technology>Tablet formulation</Technology></Technologies><Summary>chronic &lt;b&gt;pain&lt;/b&gt;, particularly&amp;nbsp;moderate-to-severe chronic low back &lt;b&gt;pain&lt;/b&gt; [ 1068296 ], [ 1959989 ]. In March 2017, Nektar was seeking to outlicense to a partner to support further clinical development and commercialization activities [ 1905179 ]. In...indication had been approved by the FDA [ 1515750 ], [ 1561056 ]; however, no further development for this indication has since been reported [ 1636539 ]. In September 2017, Nektar was listing moderate-to-severe chronic low back &lt;b&gt;pain&lt;/b&gt; as the only indication in development</Summary><IndicationsSecondary><Indication>Pain</Indication></IndicationsSecondary><ActionsSecondary><Action>Analgesic</Action></ActionsSecondary><AddedDate>2010-01-13T00:00:00Z</AddedDate></Drug><Drug id="42998" name="tanezumab" lastModificationDate="2019-06-20T00:00:00Z" phaseHighest="Phase 3 Clinical"><CompanyOriginator>Rinat-Pfizer Inc</CompanyOriginator><CompaniesPrimary><Company>Eli Lilly &amp; Co</Company><Company>Pfizer Inc</Company></CompaniesPrimary><RegulatoryDesignations><RegulatoryDesignation>Fast Track</RegulatoryDesignation><RegulatoryDesignation>Paediatric Investigation Plan</RegulatoryDesignation></RegulatoryDesignations><IndicationsPrimary><Indication>Cancer pain</Indication><Indication>Lower back pain</Indication><Indication>Osteoarthritis</Indication><Indication>Pain</Indication></IndicationsPrimary><ActionsPrimary><Action>NGF receptor antagonist</Action><Action>Nerve growth factor ligand inhibitor</Action></ActionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Intravenous formulation</Technology><Technology>Monoclonal antibody humanized</Technology><Technology>Protein recombinant</Technology><Technology>Subcutaneous formulation</Technology></Technologies><Summary>chronic &lt;b&gt;pain&lt;/b&gt;, including in patients with osteoarthritis (OA), chronic low back &lt;b&gt;pain&lt;/b&gt; (CLBP) and cancer &lt;b&gt;pain&lt;/b&gt; [ 473984 ], [ 1493507 ], [ 1663448...OA &lt;b&gt;pain&lt;/b&gt; trial (A4091057) [ 2114755 ]; in February 2019, further data from the OA &lt;b&gt;pain&lt;/b&gt; program were expected later that year [ 2121188 ]. A...year [ 2121188 ]. In October 2015, a phase III trial in patients with cancer &lt;b&gt;pain&lt;/b&gt; due to bone metastasis was initiated [ 1730724 ]; in February 2019, the trial was</Summary><CompaniesSecondary><Company>Genentech Inc</Company><Company>Rinat-Pfizer Inc</Company></CompaniesSecondary><IndicationsSecondary><Indication>Diabetic neuropathy</Indication><Indication>Ostealgia</Indication></IndicationsSecondary><ActionsSecondary><Action>Analgesic</Action><Action>Anti-inflammatory</Action></ActionsSecondary><AddedDate>2002-12-13T00:00:00Z</AddedDate></Drug><Drug id="68827" name="mirogabalin besylate" lastModificationDate="2019-07-02T00:00:00Z" phaseHighest="Launched"><CompanyOriginator>Daiichi Sankyo Co Ltd</CompanyOriginator><CompaniesPrimary><Company>Daiichi Sankyo Co Ltd</Company></CompaniesPrimary><IndicationsPrimary><Indication>Neuropathic pain</Indication></IndicationsPrimary><ActionsPrimary><Action>CACNA2D1 calcium channel subunit stimulator</Action></ActionsPrimary><Technologies><Technology>Oral formulation</Technology><Technology>Small molecule therapeutic</Technology><Technology>Tablet formulation</Technology></Technologies><Summary>neuropathic &lt;b&gt;pain&lt;/b&gt; [ 2141415 ]. In November 2011, a phase II study was initiated in patients with diabetic peripheral neuropathic &lt;b&gt;pain&lt;/b&gt; (DPNP) in the US; in January 2013, the trial was completed [ 1252089 ]; in October 2018...March 2019, the phase 3 clinical trial (AMELA) to evaluate the drug in patients with post-spinal cord injury neuropathic &lt;b&gt;pain&lt;/b&gt; was initiated [ 2135128 ]. The company was also previously developing the agent for fibromyalgia. In October 2014, the</Summary><IndicationsSecondary><Indication>Fibromyalgia</Indication><Indication>Pain</Indication><Indication>Postherpetic neuralgia</Indication></IndicationsSecondary><ActionsSecondary><Action>Analgesic</Action></ActionsSecondary><AddedDate>2010-11-01T00:00:00Z</AddedDate></Drug></SearchResults><Filters total="15"><Filter label="Drug Sales 2010 (USD M)" name="drugSalesYearActual" total="5"><FilterOption count="508" label="&lt; 100"/><FilterOption count="105" label="≥ 100 and  250"/><FilterOption count="87" label="≥ 250 and  500"/><FilterOption count="61" label="≥ 500 and  1000"/><FilterOption count="99" label="≥ 1000"/></Filter><Filter label="Secondary Actions" name="actionsSecondary" total="100"><FilterOption id="2946" count="3144" label="Analgesic"/><FilterOption id="2953" count="874" label="Anti-inflammatory"/><FilterOption id="59620" count="752" label="Unspecified drug target"/><FilterOption id="1545" count="643" label="Anticancer"/><FilterOption id="2955" count="382" label="Non-steroidal anti-inflammatory"/><FilterOption id="1615" count="263" label="Neuroprotectant"/><FilterOption id="70" count="172" label="Anticonvulsant agent"/><FilterOption id="2941" count="165" label="Antidepressant"/><FilterOption id="62255" count="163" label="Anticancer protein kinase inhibitor"/><FilterOption id="991" count="156" label="Antiviral"/><FilterOption id="1589" count="121" label="Apoptosis stimulator"/><FilterOption id="2942" count="119" label="Anxiolytic"/><FilterOption id="2657" count="108" label="Antihypertensive"/><FilterOption id="55685" count="106" label="Anticancer monoclonal antibody"/><FilterOption id="285" count="97" label="Norepinephrine uptake inhibitor"/><FilterOption id="399" count="93" label="Hypoglycemic agent"/><FilterOption id="3" count="89" label="5-HT uptake inhibitor"/><FilterOption id="61" count="89" label="Angiogenesis inhibitor"/><FilterOption id="2943" count="88" label="Antipsychotic"/><FilterOption id="12378" count="88" label="Prophylactic vaccine"/><FilterOption id="1596" count="85" label="Immunomodulator"/><FilterOption id="2947" count="83" label="Antiparkinsonian"/><FilterOption id="284" count="79" label="Nootropic agent"/><FilterOption id="393" count="78" label="Immunostimulant"/><FilterOption id="12379" count="76" label="Therapeutic vaccine"/><FilterOption id="2970" count="73" label="Anti-emetic"/><FilterOption id="7293" count="73" label="Synergist"/><FilterOption id="1594" count="68" label="Antibacterial"/><FilterOption id="1332" count="67" label="Gastrointestinal system agent"/><FilterOption id="1669" count="65" label="Local anesthetic"/><FilterOption id="388" count="63" label="Vasodilator"/><FilterOption id="15184" count="61" label="Systemic antipsoriatic product"/><FilterOption id="15128" count="59" label="Ophthalmological agent"/><FilterOption id="329" count="58" label="Prostaglandin synthesis inhibitor"/><FilterOption id="767" count="56" label="Cell cycle inhibitor"/><FilterOption id="2939" count="51" label="CNS modulator"/><FilterOption id="7761" count="45" label="T-lymphocyte stimulator"/><FilterOption id="396" count="42" label="Immunosuppressant"/><FilterOption id="312" count="40" label="Platelet aggregation inhibitor"/><FilterOption id="89" count="39" label="Bone resorption inhibitor"/><FilterOption id="2954" count="39" label="Steroidal anti-inflammatory"/><FilterOption id="12372" count="38" label="Protein subunit vaccine"/><FilterOption id="2944" count="32" label="Hypnotic"/><FilterOption id="7292" count="32" label="Vulnerary agent"/><FilterOption id="646" count="28" label="Bronchodilator"/><FilterOption id="3189" count="28" label="Corticosteroid agonist"/><FilterOption id="2659" count="27" label="Cardioprotectant"/><FilterOption id="695" count="27" label="Metastasis inhibitor"/><FilterOption id="4155" count="26" label="Imaging agent"/><FilterOption id="2575" count="26" label="Microtubule inhibitor"/><FilterOption id="664" count="25" label="Fibrosuppressant"/><FilterOption id="5557" count="25" label="Muscle relaxant"/><FilterOption id="2660" count="24" label="Vasoprotectant"/><FilterOption id="62" count="23" label="Angiogenesis stimulator"/><FilterOption id="793" count="23" label="Gastroprokinetic"/><FilterOption id="15180" count="23" label="Topical antipruritic product"/><FilterOption id="7210" count="22" label="Cardiovascular diagnostic agent"/><FilterOption id="71" count="21" label="Antihypercholesterolemic agent"/><FilterOption id="151" count="21" label="Dopamine uptake inhibitor"/><FilterOption id="610" count="21" label="Hematopoietic stimulator"/><FilterOption id="7220" count="21" label="Neoplasm diagnostic agent"/><FilterOption id="12596" count="21" label="Osteoclast inhibitor"/><FilterOption id="74" count="20" label="Antioxidant agent"/><FilterOption id="2667" count="19" label="Antiarteriosclerotic"/><FilterOption id="7294" count="19" label="Antisense oligonucleotide inhibitor"/><FilterOption id="1748" count="19" label="Fungicide"/><FilterOption id="4788" count="19" label="Plasmid based gene therapy"/><FilterOption id="4781" count="18" label="Adeno-associated virus based gene therapy"/><FilterOption id="524" count="18" label="Adjuvant"/><FilterOption id="1538" count="18" label="Bacterial protein synthesis inhibitor"/><FilterOption id="1880" count="18" label="Dermatological agent"/><FilterOption id="2940" count="18" label="Psychomodulator"/><FilterOption id="5720" count="18" label="Radiodiagnostic"/><FilterOption id="12370" count="18" label="Recombinant viral vector vaccine"/><FilterOption id="1470" count="18" label="Respiratory system agent"/><FilterOption id="26035" count="18" label="siRNA agent"/><FilterOption id="945" count="18" label="Vascular agent"/><FilterOption id="15135" count="17" label="Antiglaucoma agent"/><FilterOption id="1625" count="17" label="Antitussive"/><FilterOption id="1840" count="17" label="Appetite suppressant"/><FilterOption id="698" count="17" label="Nitric oxide donor"/><FilterOption id="726" count="17" label="Vasoconstrictor"/><FilterOption id="965" count="16" label="Cardiovascular agent"/><FilterOption id="968" count="16" label="Coagulation stimulator"/><FilterOption id="4790" count="16" label="Genetically engineered autologous cell therapy"/><FilterOption id="886" count="16" label="Opioid modulator"/><FilterOption id="463" count="16" label="Ribosome binding agent"/><FilterOption id="15187" count="16" label="Systemic dermatological antibacterial product"/><FilterOption id="4780" count="15" label="Adenovirus based gene therapy"/><FilterOption id="72" count="15" label="Antihyperlipidemic agent"/><FilterOption id="659" count="15" label="Coagulation inhibitor"/><FilterOption id="12367" count="15" label="Inactivated viral vaccine"/><FilterOption id="450" count="15" label="Neuromuscular blocking agent"/><FilterOption id="15148" count="15" label="Ocular antineovascularisation agent"/><FilterOption id="15183" count="15" label="Topical antipsoriatic product"/><FilterOption id="449" count="14" label="Antiarrhythmic agent"/><FilterOption id="50" count="14" label="Anticancer alkylating agent"/><FilterOption id="38439" count="14" label="DPP IV inhibitor antidiabetic product"/><FilterOption id="7251" count="14" label="Female contraceptive"/><FilterOption id="871" count="14" label="GABA modulator"/></Filter><Filter label="Drug Deal Types" name="drugDealTypes" total="20"><FilterOption id="4" count="1442" label="Drug - Development/Commercialization License"/><FilterOption id="5" count="672" label="Drug - Commercialization License"/><FilterOption id="13" count="575" label="Drug - Funding"/><FilterOption id="6" count="527" label="Drug - Manufacturing/Supply"/><FilterOption id="3" count="443" label="Drug - Early Research/Development"/><FilterOption id="7" count="405" label="Drug - Development Services"/><FilterOption id="10" count="216" label="Technology - Other Proprietary"/><FilterOption id="11" count="215" label="Patent - Exclusive Rights"/><FilterOption id="14" count="176" label="Drug - Asset Divestment"/><FilterOption id="2" count="156" label="Drug - Screening/Evaluation"/><FilterOption id="8" count="136" label="Technology - Delivery/Formulation"/><FilterOption id="20" count="103" label="Company - M&amp;A (in whole or part)"/><FilterOption id="12" count="69" label="Patent - Non-Exclusive Rights"/><FilterOption id="15" count="66" label="Drug - CRADA"/><FilterOption id="1" count="33" label="Drug - Discovery/Design"/><FilterOption id="21" count="24" label="Patent - Litigation Settlement"/><FilterOption id="19" count="18" label="Company - Joint Venture"/><FilterOption id="17" count="13" label="Patent - Asset Divestment"/><FilterOption id="16" count="9" label="Technology - Asset Divestment"/><FilterOption id="9" count="5" label="Technology - Target Validation"/></Filter><Filter label="Drug Forecast 2015 (USD M)" name="drugSalesYearEstimate" total="5"><FilterOption count="276" label="&lt; 100"/><FilterOption count="119" label="≥ 100 and  250"/><FilterOption count="97" label="≥ 250 and  500"/><FilterOption count="73" label="≥ 500 and  1000"/><FilterOption count="113" label="≥ 1000"/></Filter><Filter label="Drug Deals Count" name="drugDealsCount" total="8"><FilterOption count="2961" label="= 0"/><FilterOption count="1089" label="&gt; 1 and ≤ 1"/><FilterOption count="520" label="&gt; 2 and ≤ 2"/><FilterOption count="288" label="&gt; 3 and ≤ 3"/><FilterOption count="213" label="&gt; 4 and ≤ 4"/><FilterOption count="122" label="&gt; 5 and ≤ 5"/><FilterOption count="287" label="&gt; 6 and ≤ 10"/><FilterOption count="105" label="&gt; 11"/></Filter><Filter label="Technologies" name="technologies" total="100"><FilterOption id="762" count="4448" label="Small molecule therapeutic"/><FilterOption id="585" count="1647" label="Oral formulation"/><FilterOption id="761" count="1074" label="Biological therapeutic"/><FilterOption id="595" count="630" label="Tablet formulation"/><FilterOption id="648" count="601" label="Intravenous formulation"/><FilterOption id="586" count="362" label="Capsule formulation"/><FilterOption id="740" count="334" label="Infusion"/><FilterOption id="175" count="324" label="Drug combination"/><FilterOption id="766" count="323" label="Parenteral formulation unspecified"/><FilterOption id="647" count="293" label="Subcutaneous formulation"/><FilterOption id="80" count="284" label="Peptide"/><FilterOption id="558" count="278" label="Transdermal formulation"/><FilterOption id="589" count="236" label="Sustained release formulation"/><FilterOption id="85" count="210" label="Protein recombinant"/><FilterOption id="746" count="187" label="Solution"/><FilterOption id="603" count="180" label="Systemic formulation unspecified"/><FilterOption id="1652" count="166" label="Prodrug"/><FilterOption id="611" count="165" label="Dermatological formulation"/><FilterOption id="751" count="164" label="Film coating"/><FilterOption id="651" count="151" label="Intramuscular formulation"/><FilterOption id="660" count="130" label="Oral sustained release formulation"/><FilterOption id="1647" count="129" label="Natural product"/><FilterOption id="596" count="123" label="Injectable formulation"/><FilterOption id="573" count="114" label="Immunoglobulin-G"/><FilterOption id="600" count="105" label="Patch formulation"/><FilterOption id="1263" count="100" label="Immuno-oncology"/><FilterOption id="898" count="97" label="Formulation powder"/><FilterOption id="169" count="96" label="Monoclonal antibody humanized"/><FilterOption id="680" count="93" label="Buccal formulation systemic"/><FilterOption id="620" count="90" label="Ophthalmic formulation"/><FilterOption id="750" count="86" label="Freeze drying"/><FilterOption id="168" count="77" label="Monoclonal antibody human"/><FilterOption id="559" count="77" label="Oral controlled release formulation"/><FilterOption id="62" count="77" label="Virus recombinant"/><FilterOption id="641" count="75" label="Controlled release formulation"/><FilterOption id="616" count="69" label="Inhalant formulation"/><FilterOption id="661" count="66" label="Oral quick release formulation"/><FilterOption id="764" count="65" label="Local formulation unspecified"/><FilterOption id="745" count="62" label="Suspension"/><FilterOption id="612" count="60" label="Emulsion dermatological"/><FilterOption id="902" count="60" label="Orally disintegrating tablet"/><FilterOption id="84" count="59" label="Protein fusion"/><FilterOption id="594" count="54" label="Oral suspension formulation"/><FilterOption id="66" count="52" label="Antibiotic"/><FilterOption id="605" count="52" label="Nasal systemic formulation"/><FilterOption id="805" count="51" label="Daily dosing"/><FilterOption id="593" count="48" label="Oral liquid formulation"/><FilterOption id="90" count="47" label="Steroid"/><FilterOption id="652" count="46" label="Intra-articular formulation"/><FilterOption id="662" count="46" label="Quick release formulation"/><FilterOption id="731" count="44" label="Imaging"/><FilterOption id="103" count="43" label="Oligonucleotide"/><FilterOption id="659" count="43" label="Ophthalmic liquid formulation"/><FilterOption id="348" count="43" label="PEGylated formulation"/><FilterOption id="775" count="39" label="Dermatological gel formulation"/><FilterOption id="570" count="37" label="Cell therapy"/><FilterOption id="347" count="37" label="Intratumoral formulation"/><FilterOption id="599" count="37" label="Nanoparticle formulation injectable"/><FilterOption id="630" count="37" label="Stereochemistry"/><FilterOption id="851" count="35" label="Intradermal formulation"/><FilterOption id="654" count="35" label="Intrathecal formulation"/><FilterOption id="590" count="34" label="Enteric coated formulation"/><FilterOption id="142" count="32" label="Liposome formulation"/><FilterOption id="207" count="32" label="Protein conjugated"/><FilterOption id="93" count="32" label="Toxin"/><FilterOption id="743" count="31" label="Granule"/><FilterOption id="51" count="31" label="Monoclonal antibody"/><FilterOption id="180" count="29" label="Antibody fragment"/><FilterOption id="770" count="29" label="Transdermal gel formulation"/><FilterOption id="1646" count="28" label="Injectable controlled release formulation"/><FilterOption id="615" count="27" label="Aerosol formulation dermatological"/><FilterOption id="1668" count="27" label="Nanoparticle formulation"/><FilterOption id="618" count="27" label="Powder formulation inhalant"/><FilterOption id="724" count="26" label="Radiolabeling"/><FilterOption id="617" count="25" label="Aerosol formulation inhalant"/><FilterOption id="560" count="25" label="Drug implant"/><FilterOption id="753" count="25" label="Microparticle formulation"/><FilterOption id="606" count="25" label="Transmucosal formulation"/><FilterOption id="897" count="24" label="Formulation aerosol"/><FilterOption id="74" count="24" label="Glycoprotein"/><FilterOption id="864" count="24" label="Mesenchymal stem cell therapy"/><FilterOption id="894" count="23" label="Liquid formulation"/><FilterOption id="856" count="22" label="Autologous stem cell therapy"/><FilterOption id="1663" count="22" label="Gel formulation"/><FilterOption id="171" count="22" label="Monoclonal antibody conjugated"/><FilterOption id="569" count="22" label="Oligonucleotide antisense"/><FilterOption id="777" count="21" label="Nasal formulation"/><FilterOption id="901" count="21" label="Recombinant enzyme"/><FilterOption id="349" count="19" label="Lipid"/><FilterOption id="667" count="19" label="Peptidomimetic"/><FilterOption id="623" count="19" label="Vaginal formulation"/><FilterOption id="1" count="18" label="Antibody"/><FilterOption id="852" count="18" label="Intravesical formulation"/><FilterOption id="159" count="18" label="Oligosaccharide"/><FilterOption id="962" count="17" label="Biosimilar product"/><FilterOption id="591" count="17" label="Nanoparticle formulation oral"/><FilterOption id="601" count="16" label="Absorption enhancer transdermal"/><FilterOption id="609" count="16" label="Buccal formulation local"/><FilterOption id="166" count="15" label="Chimeric monoclonal antibody"/><FilterOption id="723" count="14" label="Drug coating"/></Filter><Filter label="Drug Added by Day" name="drugAddedDateByDay" total="100"><FilterOption count="739" label="1996-02-16"/><FilterOption count="27" label="2016-10-27"/><FilterOption count="22" label="2014-04-09"/><FilterOption count="20" label="2015-08-01"/><FilterOption count="15" label="2016-08-31"/><FilterOption count="13" label="2011-04-20"/><FilterOption count="12" label="2015-05-14"/><FilterOption count="11" label="2011-06-08"/><FilterOption count="10" label="2013-12-04"/><FilterOption count="10" label="2017-11-06"/><FilterOption count="9" label="2003-03-27"/><FilterOption count="9" label="2010-10-14"/><FilterOption count="9" label="2015-05-13"/><FilterOption count="9" label="2015-06-22"/><FilterOption count="8" label="2003-03-25"/><FilterOption count="8" label="2009-03-23"/><FilterOption count="8" label="2017-01-11"/><FilterOption count="8" label="2018-10-15"/><FilterOption count="7" label="2012-06-01"/><FilterOption count="7" label="2012-09-28"/><FilterOption count="7" label="2013-10-18"/><FilterOption count="7" label="2018-03-20"/><FilterOption count="6" label="2010-07-09"/><FilterOption count="6" label="2011-03-30"/><FilterOption count="6" label="2011-04-19"/><FilterOption count="6" label="2011-08-25"/><FilterOption count="6" label="2011-11-26"/><FilterOption count="6" label="2016-12-20"/><FilterOption count="6" label="2017-01-30"/><FilterOption count="6" label="2017-08-14"/><FilterOption count="5" label="1996-06-17"/><FilterOption count="5" label="1996-07-01"/><FilterOption count="5" label="1996-09-04"/><FilterOption count="5" label="1997-10-16"/><FilterOption count="5" label="2002-12-16"/><FilterOption count="5" label="2008-09-29"/><FilterOption count="5" label="2009-03-10"/><FilterOption count="5" label="2013-08-30"/><FilterOption count="5" label="2015-04-29"/><FilterOption count="5" label="2015-11-02"/><FilterOption count="4" label="1996-04-19"/><FilterOption count="4" label="1996-05-24"/><FilterOption count="4" label="1996-08-19"/><FilterOption count="4" label="1996-09-19"/><FilterOption count="4" label="1996-11-18"/><FilterOption count="4" label="1997-02-11"/><FilterOption count="4" label="1998-03-19"/><FilterOption count="4" label="1998-10-26"/><FilterOption count="4" label="2001-02-22"/><FilterOption count="4" label="2003-03-26"/><FilterOption count="4" label="2003-06-25"/><FilterOption count="4" label="2004-05-25"/><FilterOption count="4" label="2005-02-11"/><FilterOption count="4" label="2005-06-28"/><FilterOption count="4" label="2005-09-28"/><FilterOption count="4" label="2006-10-16"/><FilterOption count="4" label="2007-08-09"/><FilterOption count="4" label="2007-09-05"/><FilterOption count="4" label="2007-11-26"/><FilterOption count="4" label="2008-10-14"/><FilterOption count="4" label="2008-11-25"/><FilterOption count="4" label="2010-07-15"/><FilterOption count="4" label="2010-07-28"/><FilterOption count="4" label="2010-10-05"/><FilterOption count="4" label="2010-11-22"/><FilterOption count="4" label="2011-02-23"/><FilterOption count="4" label="2011-05-03"/><FilterOption count="4" label="2011-07-05"/><FilterOption count="4" label="2011-07-22"/><FilterOption count="4" label="2012-01-19"/><FilterOption count="4" label="2012-05-18"/><FilterOption count="4" label="2012-08-21"/><FilterOption count="4" label="2013-10-30"/><FilterOption count="4" label="2014-11-18"/><FilterOption count="4" label="2014-12-16"/><FilterOption count="4" label="2015-05-20"/><FilterOption count="4" label="2015-06-18"/><FilterOption count="4" label="2015-10-30"/><FilterOption count="4" label="2016-07-25"/><FilterOption count="4" label="2019-01-08"/><FilterOption count="3" label="1996-02-27"/><FilterOption count="3" label="1996-04-04"/><FilterOption count="3" label="1996-04-10"/><FilterOption count="3" label="1996-04-18"/><FilterOption count="3" label="1996-05-28"/><FilterOption count="3" label="1996-06-13"/><FilterOption count="3" label="1996-07-26"/><FilterOption count="3" label="1996-09-30"/><FilterOption count="3" label="1997-09-19"/><FilterOption count="3" label="1998-04-23"/><FilterOption count="3" label="1998-06-08"/><FilterOption count="3" label="1998-10-07"/><FilterOption count="3" label="1998-11-10"/><FilterOption count="3" label="1998-11-16"/><FilterOption count="3" label="1999-07-22"/><FilterOption count="3" label="1999-09-15"/><FilterOption count="3" label="1999-10-20"/><FilterOption count="3" label="1999-12-14"/><FilterOption count="3" label="2000-04-05"/><FilterOption count="3" label="2000-05-04"/></Filter><Filter label="Drug Has Financials" name="drugHasFinancials" total="2"><FilterOption count="4736" label="No"/><FilterOption count="849" label="Yes"/></Filter><Filter label="Secondary Companies" name="companiesSecondary" total="100"><FilterOption id="18767" count="150" label="Pfizer Inc"/><FilterOption id="28355" count="98" label="GlaxoSmithKline plc"/><FilterOption id="18077" count="90" label="Merck &amp; Co Inc"/><FilterOption id="13601" count="79" label="Abbott Laboratories"/><FilterOption id="17810" count="71" label="Eli Lilly &amp; Co"/><FilterOption id="14190" count="68" label="AstraZeneca plc"/><FilterOption id="23137" count="58" label="Novartis AG"/><FilterOption id="15065" count="51" label="Bristol-Myers Squibb Co"/><FilterOption id="16453" count="48" label="Glaxo Group Ltd"/><FilterOption id="1009547" count="44" label="Sanofi SA"/><FilterOption id="19711" count="38" label="Schering-Plough Corp"/><FilterOption id="14109" count="37" label="Amgen Inc"/><FilterOption id="19446" count="37" label="Roche Holding AG"/><FilterOption id="19962" count="35" label="SmithKline Beecham plc"/><FilterOption id="1013295" count="31" label="Astellas Pharma Inc"/><FilterOption id="14112" count="31" label="Wyeth"/><FilterOption id="15873" count="29" label="Elan Corp plc"/><FilterOption id="14042" count="28" label="Allergan Inc"/><FilterOption id="1018015" count="28" label="Signature Therapeutics Inc"/><FilterOption id="20300" count="28" label="Takeda Pharmaceutical Co Ltd"/><FilterOption id="17332" count="27" label="Johnson &amp; Johnson"/><FilterOption id="26192" count="26" label="Endo Health Solutions Inc"/><FilterOption id="20805" count="26" label="Parke-Davis &amp; Co"/><FilterOption id="26494" count="24" label="Sanofi-Synthelabo"/><FilterOption id="14881" count="23" label="Boehringer Ingelheim International GmbH"/><FilterOption id="1072507" count="22" label="AbbVie Inc"/><FilterOption id="14455" count="22" label="Bayer AG"/><FilterOption id="16198" count="22" label="Forest Laboratories Inc"/><FilterOption id="19862" count="22" label="Merck Serono SA"/><FilterOption id="24652" count="22" label="Shire plc"/><FilterOption id="20967" count="22" label="Yamanouchi Pharmaceutical Co Ltd"/><FilterOption id="15872" count="21" label="Eisai Co Ltd"/><FilterOption id="16227" count="21" label="Fujisawa Pharmaceutical Co Ltd"/><FilterOption id="19858" count="21" label="Sunovion Pharmaceuticals Inc"/><FilterOption id="27476" count="20" label="Cassava Sciences Inc"/><FilterOption id="20518" count="20" label="National Institutes of Health"/><FilterOption id="16881" count="19" label="Astra AB"/><FilterOption id="19687" count="19" label="Bayer Schering Pharma AG"/><FilterOption id="18504" count="19" label="NeuroSearch A/S"/><FilterOption id="27638" count="19" label="Pharmacia Corp"/><FilterOption id="16955" count="19" label="Zeneca Group plc"/><FilterOption id="23401" count="18" label="Adolor Corp"/><FilterOption id="19453" count="18" label="Genentech Inc"/><FilterOption id="16587" count="18" label="Grunenthal GmbH"/><FilterOption id="22006" count="18" label="Pharmacia &amp; Upjohn Inc"/><FilterOption id="20348" count="18" label="Teva Pharmaceutical Industries Ltd"/><FilterOption id="18362" count="17" label="GD Searle &amp; Co"/><FilterOption id="25218" count="16" label="Aventis Pharma AG"/><FilterOption id="28893" count="16" label="King Pharmaceuticals Inc"/><FilterOption id="17808" count="16" label="Ligand Pharmaceuticals Inc"/><FilterOption id="24191" count="16" label="Purdue Pharma LP"/><FilterOption id="19658" count="16" label="Sankyo Co Ltd"/><FilterOption id="16299" count="16" label="Sanofi Genzyme"/><FilterOption id="26864" count="15" label="Bristol-Myers Squibb Pharma Co"/><FilterOption id="15414" count="15" label="Chugai Pharmaceutical Co Ltd"/><FilterOption id="24437" count="15" label="Ciba-Geigy AG"/><FilterOption id="25224" count="15" label="Hoechst Marion Roussel Inc"/><FilterOption id="15266" count="14" label="BTG plc"/><FilterOption id="1017506" count="14" label="Daiichi Sankyo Co Ltd"/><FilterOption id="13880" count="14" label="MSD OSS BV"/><FilterOption id="20787" count="14" label="Warner-Lambert Co"/><FilterOption id="14437" count="13" label="Baxter International Inc"/><FilterOption id="26414" count="13" label="Elan Pharmaceuticals Inc"/><FilterOption id="26178" count="13" label="F Hoffmann-La Roche AG"/><FilterOption id="18954" count="13" label="Meda AB"/><FilterOption id="18101" count="13" label="Merck KGaA"/><FilterOption id="1037462" count="13" label="Nectid Inc"/><FilterOption id="17221" count="13" label="Nektar Therapeutics"/><FilterOption id="23741" count="13" label="NicOx SA"/><FilterOption id="19863" count="13" label="Servier"/><FilterOption id="1009157" count="13" label="Theraquest Biosciences Inc"/><FilterOption id="1088700" count="12" label="Allergan plc"/><FilterOption id="1109518" count="12" label="Baxalta Inc"/><FilterOption id="27053" count="12" label="Glaxo Group Research Ltd"/><FilterOption id="18008" count="12" label="MedImmune LLC"/><FilterOption id="27477" count="12" label="Paladin Labs Inc"/><FilterOption id="15336" count="12" label="UCB Celltech"/><FilterOption id="23780" count="11" label="Actelion Ltd"/><FilterOption id="14095" count="11" label="ALZA Corp"/><FilterOption id="15623" count="11" label="ASTA Medica AG"/><FilterOption id="27279" count="11" label="CeNeS Pharmaceuticals plc"/><FilterOption id="15385" count="11" label="Chiron Corp"/><FilterOption id="29481" count="11" label="Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC"/><FilterOption id="20519" count="11" label="National Cancer Institute"/><FilterOption id="18681" count="11" label="Ono Pharmaceutical Co Ltd"/><FilterOption id="18717" count="11" label="Otsuka Pharmaceutical Co Ltd"/><FilterOption id="20665" count="11" label="University of Queensland"/><FilterOption id="27224" count="10" label="ACADIA Pharmaceuticals Inc"/><FilterOption id="27254" count="10" label="Aventis SA"/><FilterOption id="15358" count="10" label="Cephalon Inc"/><FilterOption id="17421" count="10" label="Janssen Pharmaceutica NV"/><FilterOption id="20983" count="10" label="Mitsubishi Pharma Corp"/><FilterOption id="17592" count="10" label="RW Johnson Pharmaceutical Research Institute"/><FilterOption id="18478" count="9" label="Alcon Inc"/><FilterOption id="1057214" count="9" label="Convergence Pharmaceuticals Ltd"/><FilterOption id="17900" count="9" label="H Lundbeck A/S"/><FilterOption id="24019" count="9" label="MSD Japan"/><FilterOption id="18995" count="9" label="Pharmacia &amp; Upjohn Co"/><FilterOption id="19072" count="9" label="Pharmos Corp"/><FilterOption id="19898" count="9" label="Shionogi &amp; Co Ltd"/></Filter><Filter label="Primary Indications" name="indicationsPrimary" total="100"><FilterOption id="20" count="689" label="Pain"/><FilterOption id="1295" count="203" label="Neuropathic pain"/><FilterOption id="188" count="99" label="Inflammatory disease"/><FilterOption id="210" count="98" label="Migraine"/><FilterOption id="245" count="93" label="Osteoarthritis"/><FilterOption id="49" count="88" label="Breast tumor"/><FilterOption id="651" count="84" label="Cancer"/><FilterOption id="291" count="74" label="Rheumatoid arthritis"/><FilterOption id="3657" count="73" label="Metastatic breast cancer"/><FilterOption id="725" count="72" label="Solid tumor"/><FilterOption id="1262" count="62" label="Non-small-cell lung cancer"/><FilterOption id="799" count="57" label="Ovary tumor"/><FilterOption id="3665" count="56" label="Metastatic non small cell lung cancer"/><FilterOption id="119" count="49" label="Epilepsy"/><FilterOption id="213" count="47" label="Multiple sclerosis"/><FilterOption id="1731" count="46" label="Acute myelogenous leukemia"/><FilterOption id="3211" count="45" label="Cancer pain"/><FilterOption id="623" count="44" label="Head and neck tumor"/><FilterOption id="2454" count="43" label="Glioblastoma"/><FilterOption id="1828" count="43" label="Multiple myeloma"/><FilterOption id="3658" count="42" label="Metastatic colorectal cancer"/><FilterOption id="3713" count="41" label="Advanced solid tumor"/><FilterOption id="989" count="41" label="Colorectal tumor"/><FilterOption id="249" count="41" label="Pancreas tumor"/><FilterOption id="837" count="39" label="Non-insulin dependent diabetes"/><FilterOption id="281" count="38" label="Psoriasis"/><FilterOption id="3257" count="37" label="Stage IV melanoma"/><FilterOption id="14" count="36" label="Alzheimers disease"/><FilterOption id="1767" count="36" label="Hepatocellular carcinoma"/><FilterOption id="319" count="36" label="Non-Hodgkin lymphoma"/><FilterOption id="3246" count="35" label="Hormone refractory prostate cancer"/><FilterOption id="205" count="33" label="Melanoma"/><FilterOption id="3669" count="32" label="Metastatic pancreas cancer"/><FilterOption id="4250" count="32" label="Metastatic renal cell carcinoma"/><FilterOption id="276" count="32" label="Prostate tumor"/><FilterOption id="337" count="32" label="Ulcerative colitis"/><FilterOption id="31" count="31" label="Asthma"/><FilterOption id="1734" count="31" label="Chronic lymphocytic leukemia"/><FilterOption id="1272" count="30" label="Myelodysplastic syndrome"/><FilterOption id="84" count="29" label="Crohns disease"/><FilterOption id="1749" count="29" label="Diffuse large B-cell lymphoma"/><FilterOption id="255" count="29" label="Parkinsons disease"/><FilterOption id="398" count="28" label="Ankylosing spondylitis"/><FilterOption id="686" count="28" label="Ocular inflammation"/><FilterOption id="3762" count="28" label="Ocular pain"/><FilterOption id="28" count="27" label="Arthritis"/><FilterOption id="1185" count="27" label="Chronic obstructive pulmonary disease"/><FilterOption id="93" count="27" label="Depression"/><FilterOption id="3466" count="27" label="Metastatic bladder cancer"/><FilterOption id="3300" count="27" label="Postherpetic neuralgia"/><FilterOption id="1781" count="27" label="Psoriatic arthritis"/><FilterOption id="1766" count="27" label="Renal cell carcinoma"/><FilterOption id="1261" count="27" label="Small-cell lung cancer"/><FilterOption id="3378" count="25" label="Soft tissue sarcoma"/><FilterOption id="307" count="25" label="Squamous cell carcinoma"/><FilterOption id="2380" count="24" label="Bladder cancer"/><FilterOption id="1705" count="24" label="Endometrioid carcinoma"/><FilterOption id="159" count="24" label="HIV-1 infection"/><FilterOption id="2243" count="23" label="Fallopian tube cancer"/><FilterOption id="1108" count="23" label="Glioma"/><FilterOption id="913" count="23" label="Muscle hypertonia"/><FilterOption id="3083" count="23" label="Peritoneal tumor"/><FilterOption id="36" count="22" label="Autoimmune disease"/><FilterOption id="3437" count="22" label="Lower back pain"/><FilterOption id="203" count="22" label="Lymphoma"/><FilterOption id="243" count="22" label="Opiate dependence"/><FilterOption id="1728" count="21" label="Acute lymphoblastic leukemia"/><FilterOption id="1745" count="21" label="Follicle center lymphoma"/><FilterOption id="212" count="21" label="Motor neurone disease"/><FilterOption id="246" count="21" label="Osteoporosis"/><FilterOption id="1011" count="20" label="Esophagus tumor"/><FilterOption id="2054" count="20" label="Hematological neoplasm"/><FilterOption id="178" count="20" label="Hypertension"/><FilterOption id="4898" count="20" label="Major depressive disorder"/><FilterOption id="3866" count="20" label="Metastatic ovary cancer"/><FilterOption id="1128" count="20" label="Neuroendocrine tumor"/><FilterOption id="1753" count="20" label="Peripheral T-cell lymphoma"/><FilterOption id="2549" count="20" label="Postmenopausal osteoporosis"/><FilterOption id="427" count="20" label="Uterine cervix tumor"/><FilterOption id="3016" count="20" label="Xerophthalmia"/><FilterOption id="1815" count="19" label="Bacterial pneumonia"/><FilterOption id="1735" count="19" label="Chronic myelocytic leukemia"/><FilterOption id="2527" count="19" label="Fibromyalgia"/><FilterOption id="158" count="19" label="HIV infection"/><FilterOption id="3247" count="19" label="Hormone dependent prostate cancer"/><FilterOption id="3673" count="19" label="Metastatic head and neck cancer"/><FilterOption id="3510" count="19" label="Pulmonary artery hypertension"/><FilterOption id="127" count="19" label="Stomach tumor"/><FilterOption id="1771" count="19" label="Transitional cell carcinoma"/><FilterOption id="55" count="18" label="Cardiac failure"/><FilterOption id="113" count="18" label="Endometriosis"/><FilterOption id="1105" count="18" label="Scleroderma"/><FilterOption id="1102" count="17" label="Atopic dermatitis"/><FilterOption id="836" count="17" label="Insulin dependent diabetes"/><FilterOption id="1744" count="17" label="Mantle cell lymphoma"/><FilterOption id="1240" count="17" label="Mesothelioma"/><FilterOption id="2637" count="17" label="Non-alcoholic steatohepatitis"/><FilterOption id="299" count="17" label="Schizophrenia"/><FilterOption id="3666" count="16" label="Metastatic stomach cancer"/><FilterOption id="2436" count="16" label="Myelofibrosis"/></Filter><Filter label="Secondary Indications" name="indicationsSecondary" total="100"><FilterOption id="20" count="1592" label="Pain"/><FilterOption id="651" count="345" label="Cancer"/><FilterOption id="188" count="344" label="Inflammatory disease"/><FilterOption id="1295" count="339" label="Neuropathic pain"/><FilterOption id="210" count="245" label="Migraine"/><FilterOption id="725" count="164" label="Solid tumor"/><FilterOption id="291" count="156" label="Rheumatoid arthritis"/><FilterOption id="49" count="121" label="Breast tumor"/><FilterOption id="119" count="103" label="Epilepsy"/><FilterOption id="93" count="101" label="Depression"/><FilterOption id="989" count="95" label="Colorectal tumor"/><FilterOption id="1262" count="94" label="Non-small-cell lung cancer"/><FilterOption id="31" count="91" label="Asthma"/><FilterOption id="245" count="89" label="Osteoarthritis"/><FilterOption id="799" count="89" label="Ovary tumor"/><FilterOption id="205" count="88" label="Melanoma"/><FilterOption id="65" count="83" label="Stroke"/><FilterOption id="276" count="82" label="Prostate tumor"/><FilterOption id="14" count="80" label="Alzheimers disease"/><FilterOption id="25" count="79" label="Anxiety disorder"/><FilterOption id="249" count="79" label="Pancreas tumor"/><FilterOption id="1828" count="62" label="Multiple myeloma"/><FilterOption id="101" count="60" label="Diabetic neuropathy"/><FilterOption id="60" count="58" label="Central nervous system disease"/><FilterOption id="281" count="58" label="Psoriasis"/><FilterOption id="677" count="57" label="Neurological disease"/><FilterOption id="3246" count="56" label="Hormone refractory prostate cancer"/><FilterOption id="3211" count="53" label="Cancer pain"/><FilterOption id="755" count="53" label="Lung tumor"/><FilterOption id="233" count="53" label="Neurodegenerative disease"/><FilterOption id="213" count="52" label="Multiple sclerosis"/><FilterOption id="255" count="52" label="Parkinsons disease"/><FilterOption id="36" count="50" label="Autoimmune disease"/><FilterOption id="3300" count="50" label="Postherpetic neuralgia"/><FilterOption id="299" count="50" label="Schizophrenia"/><FilterOption id="192" count="47" label="Irritable bowel syndrome"/><FilterOption id="2527" count="46" label="Fibromyalgia"/><FilterOption id="623" count="45" label="Head and neck tumor"/><FilterOption id="84" count="44" label="Crohns disease"/><FilterOption id="319" count="43" label="Non-Hodgkin lymphoma"/><FilterOption id="1731" count="42" label="Acute myelogenous leukemia"/><FilterOption id="158" count="41" label="HIV infection"/><FilterOption id="28" count="39" label="Arthritis"/><FilterOption id="57" count="39" label="Cardiovascular disease"/><FilterOption id="189" count="39" label="Inflammatory bowel disease"/><FilterOption id="2454" count="38" label="Glioblastoma"/><FilterOption id="1108" count="37" label="Glioma"/><FilterOption id="4250" count="37" label="Metastatic renal cell carcinoma"/><FilterOption id="110" count="35" label="Emesis"/><FilterOption id="1272" count="35" label="Myelodysplastic syndrome"/><FilterOption id="837" count="35" label="Non-insulin dependent diabetes"/><FilterOption id="178" count="34" label="Hypertension"/><FilterOption id="194" count="34" label="Sarcoma"/><FilterOption id="127" count="34" label="Stomach tumor"/><FilterOption id="1261" count="33" label="Small-cell lung cancer"/><FilterOption id="1767" count="32" label="Hepatocellular carcinoma"/><FilterOption id="1734" count="29" label="Chronic lymphocytic leukemia"/><FilterOption id="1185" count="29" label="Chronic obstructive pulmonary disease"/><FilterOption id="353" count="29" label="Cognitive disorder"/><FilterOption id="238" count="29" label="Obesity"/><FilterOption id="55" count="28" label="Cardiac failure"/><FilterOption id="203" count="28" label="Lymphoma"/><FilterOption id="246" count="28" label="Osteoporosis"/><FilterOption id="767" count="27" label="Colon tumor"/><FilterOption id="1766" count="26" label="Renal cell carcinoma"/><FilterOption id="588" count="25" label="Drug dependence"/><FilterOption id="212" count="25" label="Motor neurone disease"/><FilterOption id="427" count="25" label="Uterine cervix tumor"/><FilterOption id="653" count="24" label="Bipolar disorder"/><FilterOption id="97" count="24" label="Diabetes mellitus"/><FilterOption id="3665" count="24" label="Metastatic non small cell lung cancer"/><FilterOption id="3257" count="24" label="Stage IV melanoma"/><FilterOption id="337" count="24" label="Ulcerative colitis"/><FilterOption id="1226" count="23" label="Age related macular degeneration"/><FilterOption id="760" count="23" label="Brain tumor"/><FilterOption id="2054" count="23" label="Hematological neoplasm"/><FilterOption id="318" count="23" label="Systemic lupus erythematosus"/><FilterOption id="187" count="23" label="Urinary incontinence"/><FilterOption id="80" count="22" label="Coronary artery disease"/><FilterOption id="134" count="22" label="Glaucoma"/><FilterOption id="199" count="22" label="Leukemia"/><FilterOption id="1011" count="21" label="Esophagus tumor"/><FilterOption id="153" count="21" label="Hepatitis C virus infection"/><FilterOption id="202" count="21" label="Liver tumor"/><FilterOption id="1867" count="21" label="Pulmonary hypertension"/><FilterOption id="1005" count="21" label="Unidentified indication"/><FilterOption id="316" count="20" label="B-cell lymphoma"/><FilterOption id="113" count="20" label="Endometriosis"/><FilterOption id="616" count="20" label="Graft versus host disease"/><FilterOption id="1240" count="20" label="Mesothelioma"/><FilterOption id="239" count="20" label="Ocular disease"/><FilterOption id="260" count="20" label="Peripheral vascular disease"/><FilterOption id="34" count="19" label="Attention deficit hyperactivity disorder"/><FilterOption id="100" count="19" label="Diabetic nephropathy"/><FilterOption id="1127" count="19" label="Fibrosis"/><FilterOption id="259" count="19" label="Peripheral neuropathy"/><FilterOption id="3083" count="19" label="Peritoneal tumor"/><FilterOption id="304" count="19" label="Sleep disorder"/><FilterOption id="3713" count="18" label="Advanced solid tumor"/><FilterOption id="1243" count="18" label="Gastroesophageal reflux"/></Filter><Filter label="Regulatory Designations" name="drugRegulatoryDesignations" total="18"><FilterOption id="1" count="741" label="Orphan Drug"/><FilterOption id="2" count="370" label="Fast Track"/><FilterOption id="11" count="146" label="Priority Review"/><FilterOption id="9" count="145" label="Paediatric Investigation Plan"/><FilterOption id="3" count="127" label="Breakthrough Therapy"/><FilterOption id="5" count="100" label="Accelerated Approval"/><FilterOption id="13" count="26" label="Rare Pediatric Disease"/><FilterOption id="16" count="22" label="Promising Innovative Medicine"/><FilterOption id="12" count="17" label="Qualified Infectious Disease Product"/><FilterOption id="10" count="12" label="PRIME"/><FilterOption id="4" count="8" label="Advanced Therapy Medicinal Product"/><FilterOption id="14" count="8" label="Sakigake"/><FilterOption id="18" count="6" label="National Science and Technology Major Project"/><FilterOption id="17" count="6" label="Regenerative Medicine Advanced Therapy"/><FilterOption id="19" count="6" label="Special Review Project"/><FilterOption id="6" count="4" label="Animal Rule"/><FilterOption id="8" count="4" label="New Active Substance"/><FilterOption id="7" count="1" label="Emergency Use Authorization"/></Filter><Filter label="Primary Actions" name="actionsPrimary" total="100"><FilterOption id="293" count="239" label="Opioid receptor mu agonist"/><FilterOption id="287" count="204" label="Opioid receptor agonist"/><FilterOption id="132" count="154" label="Cyclooxygenase inhibitor"/><FilterOption id="1001" count="135" label="Cyclooxygenase 2 inhibitor"/><FilterOption id="498" count="116" label="Sodium channel inhibitor"/><FilterOption id="291" count="88" label="Opioid receptor kappa agonist"/><FilterOption id="10" count="80" label="5-HT 1d receptor agonist"/><FilterOption id="281" count="68" label="NMDA receptor antagonist"/><FilterOption id="289" count="57" label="Opioid receptor delta agonist"/><FilterOption id="266" count="55" label="NK1 receptor antagonist"/><FilterOption id="8" count="51" label="5-HT 1b receptor agonist"/><FilterOption id="2581" count="50" label="Cannabinoid CB2 receptor agonist"/><FilterOption id="24308" count="48" label="SCN9A sodium channel subunit inhibitor"/><FilterOption id="6938" count="48" label="Vanilloid VR1 antagonist"/><FilterOption id="795" count="43" label="Cannabinoid receptor agonist"/><FilterOption id="93" count="35" label="Calcium channel inhibitor"/><FilterOption id="294" count="30" label="Opioid receptor mu antagonist"/><FilterOption id="1183" count="29" label="CGRP receptor antagonist"/><FilterOption id="2634" count="28" label="ORL1 receptor agonist"/><FilterOption id="15" count="27" label="5-HT 3 receptor antagonist"/><FilterOption id="624" count="26" label="Progesterone receptor agonist"/><FilterOption id="3191" count="25" label="Glucocorticoid receptor agonist"/><FilterOption id="288" count="25" label="Opioid receptor antagonist"/><FilterOption id="33" count="24" label="Alpha 2 adrenoceptor agonist"/><FilterOption id="6937" count="24" label="Vanilloid VR1 agonist"/><FilterOption id="2590" count="23" label="Calcium channel inhibitor N-type"/><FilterOption id="2579" count="23" label="Cannabinoid CB1 receptor agonist"/><FilterOption id="7061" count="22" label="Fatty acid amide hydrolase inhibitor"/><FilterOption id="173" count="21" label="GABA receptor agonist"/><FilterOption id="4865" count="21" label="P2X3 purinoceptor antagonist"/><FilterOption id="6" count="19" label="5-HT 1a receptor agonist"/><FilterOption id="585" count="19" label="5-HT 2a receptor antagonist"/><FilterOption id="247" count="19" label="5-Lipoxygenase inhibitor"/><FilterOption id="3808" count="19" label="Kit tyrosine kinase inhibitor"/><FilterOption id="264" count="19" label="NGF receptor antagonist"/><FilterOption id="1115" count="19" label="Opioid receptor modulator"/><FilterOption id="3840" count="19" label="TrkA receptor antagonist"/><FilterOption id="24281" count="19" label="Voltage gated sodium channel inhibitor"/><FilterOption id="999" count="18" label="Cyclooxygenase 1 inhibitor"/><FilterOption id="536" count="18" label="Estradiol agonist"/><FilterOption id="208" count="18" label="H+ K+ ATPase inhibitor"/><FilterOption id="290" count="18" label="Opioid receptor delta antagonist"/><FilterOption id="3848" count="18" label="VEGF-2 receptor antagonist"/><FilterOption id="790" count="17" label="Bradykinin B1 receptor antagonist"/><FilterOption id="17217" count="17" label="GABA A receptor alpha-2 subunit stimulator"/><FilterOption id="1098" count="16" label="Calcium channel modulator"/><FilterOption id="740" count="16" label="Epidermal growth factor receptor antagonist"/><FilterOption id="55116" count="16" label="Opioid receptor mu partial agonist"/><FilterOption id="2419" count="16" label="p38 MAP kinase inhibitor"/><FilterOption id="24311" count="16" label="SCN10A sodium channel subunit inhibitor"/><FilterOption id="440" count="15" label="5-HT 4 receptor agonist"/><FilterOption id="17247" count="15" label="GABA A receptor delta subunit stimulator"/><FilterOption id="1117" count="15" label="Opioid receptor mu modulator"/><FilterOption id="4877" count="15" label="P2X7 purinoceptor antagonist"/><FilterOption id="1728" count="15" label="Unspecified GPCR modulator"/><FilterOption id="40" count="14" label="Beta 2 adrenoceptor agonist"/><FilterOption id="2589" count="14" label="Calcium channel inhibitor T-type"/><FilterOption id="5537" count="14" label="Dipeptidyl peptidase IV inhibitor"/><FilterOption id="3806" count="14" label="Flt3 tyrosine kinase inhibitor"/><FilterOption id="23014" count="14" label="Insulin ligand"/><FilterOption id="400" count="14" label="Insulin receptor agonist"/><FilterOption id="253" count="14" label="Matrix metalloprotease inhibitor"/><FilterOption id="2412" count="14" label="Metabotropic glutamate receptor 5 antagonist"/><FilterOption id="275" count="14" label="Nicotinic acetylcholine receptor agonist"/><FilterOption id="406" count="14" label="Oxidoreductase inhibitor"/><FilterOption id="321" count="14" label="PGE1 agonist"/><FilterOption id="381" count="14" label="TNF alpha ligand inhibitor"/><FilterOption id="13" count="13" label="5-HT 2 receptor antagonist"/><FilterOption id="3151" count="13" label="GCSF receptor agonist"/><FilterOption id="9422" count="13" label="Unspecified ion channel modulator"/><FilterOption id="1722" count="13" label="VEGF receptor antagonist"/><FilterOption id="162" count="12" label="Acetylcholine receptor antagonist"/><FilterOption id="53" count="12" label="AMPA receptor antagonist"/><FilterOption id="59" count="12" label="Androgen receptor agonist"/><FilterOption id="138" count="12" label="DNA polymerase inhibitor"/><FilterOption id="150" count="12" label="Dopamine D2 receptor antagonist"/><FilterOption id="401" count="12" label="Estrogen receptor agonist"/><FilterOption id="259" count="12" label="Muscarinic receptor antagonist"/><FilterOption id="1103" count="12" label="Sodium channel modulator"/><FilterOption id="789" count="11" label="Bradykinin B2 receptor antagonist"/><FilterOption id="3154" count="11" label="CSF-1 antagonist"/><FilterOption id="3756" count="11" label="Erbb2 tyrosine kinase receptor inhibitor"/><FilterOption id="205" count="11" label="HMG CoA reductase inhibitor"/><FilterOption id="260" count="11" label="Muscarinic M1 receptor agonist"/><FilterOption id="292" count="11" label="Opioid receptor kappa antagonist"/><FilterOption id="327" count="11" label="PGI2 agonist"/><FilterOption id="40695" count="11" label="TRP cation channel A1 inhibitor"/><FilterOption id="15422" count="11" label="TRP cation channel M8 inhibitor"/><FilterOption id="499" count="11" label="Tubulin binding agent"/><FilterOption id="34" count="10" label="Alpha 2 adrenoceptor antagonist"/><FilterOption id="1263" count="10" label="Cannabinoid receptor modulator"/><FilterOption id="1914" count="10" label="Cathepsin S inhibitor"/><FilterOption id="115" count="10" label="Factor VIII agonist"/><FilterOption id="203" count="10" label="Histamine H3 receptor antagonist"/><FilterOption id="1919" count="10" label="Insulin sensitizer"/><FilterOption id="385" count="10" label="Protein tyrosine kinase inhibitor"/><FilterOption id="24306" count="10" label="SCN9A sodium channel subunit modulator"/><FilterOption id="721" count="10" label="TNF binding agent"/><FilterOption id="19" count="9" label="Acetylcholinesterase inhibitor"/><FilterOption id="595" count="9" label="Adenosine A2a receptor agonist"/></Filter><Filter label="Primary Companies" name="companiesPrimary" total="100"><FilterOption id="18767" count="90" label="Pfizer Inc"/><FilterOption id="23137" count="76" label="Novartis AG"/><FilterOption id="18077" count="63" label="Merck &amp; Co Inc"/><FilterOption id="28355" count="52" label="GlaxoSmithKline plc"/><FilterOption id="14190" count="44" label="AstraZeneca plc"/><FilterOption id="1088700" count="42" label="Allergan plc"/><FilterOption id="1013295" count="38" label="Astellas Pharma Inc"/><FilterOption id="1009547" count="37" label="Sanofi SA"/><FilterOption id="17810" count="36" label="Eli Lilly &amp; Co"/><FilterOption id="15872" count="35" label="Eisai Co Ltd"/><FilterOption id="20300" count="35" label="Takeda Pharmaceutical Co Ltd"/><FilterOption id="17332" count="31" label="Johnson &amp; Johnson"/><FilterOption id="15414" count="30" label="Chugai Pharmaceutical Co Ltd"/><FilterOption id="14455" count="29" label="Bayer AG"/><FilterOption id="17058" count="28" label="Bausch Health Companies Inc"/><FilterOption id="19446" count="28" label="Roche Holding AG"/><FilterOption id="16587" count="27" label="Grunenthal GmbH"/><FilterOption id="24652" count="27" label="Shire plc"/><FilterOption id="19898" count="26" label="Shionogi &amp; Co Ltd"/><FilterOption id="1017506" count="25" label="Daiichi Sankyo Co Ltd"/><FilterOption id="14061" count="23" label="Almirall Prodesfarma SA"/><FilterOption id="15065" count="23" label="Bristol-Myers Squibb Co"/><FilterOption id="20348" count="23" label="Teva Pharmaceutical Industries Ltd"/><FilterOption id="1072507" count="21" label="AbbVie Inc"/><FilterOption id="18439" count="21" label="Mylan NV"/><FilterOption id="18681" count="21" label="Ono Pharmaceutical Co Ltd"/><FilterOption id="14109" count="20" label="Amgen Inc"/><FilterOption id="1042596" count="19" label="Kyowa Hakko Kirin Co Ltd"/><FilterOption id="1035060" count="18" label="Mitsubishi Tanabe Pharma Corp"/><FilterOption id="1045514" count="18" label="Mundipharma International Corp Ltd"/><FilterOption id="27477" count="18" label="Paladin Labs Inc"/><FilterOption id="16450" count="17" label="Gilead Sciences Inc"/><FilterOption id="14881" count="16" label="Boehringer Ingelheim International GmbH"/><FilterOption id="15587" count="16" label="Daewoong Pharmaceutical Co Ltd"/><FilterOption id="19453" count="16" label="Genentech Inc"/><FilterOption id="1113858" count="16" label="Seqirus"/><FilterOption id="20452" count="15" label="UCB SA"/><FilterOption id="15331" count="13" label="Celgene Corp"/><FilterOption id="18717" count="13" label="Otsuka Pharmaceutical Co Ltd"/><FilterOption id="13601" count="12" label="Abbott Laboratories"/><FilterOption id="19986" count="12" label="Handok Inc"/><FilterOption id="19862" count="12" label="Merck Serono SA"/><FilterOption id="14303" count="11" label="Asahi Kasei Pharma Corp"/><FilterOption id="1063950" count="11" label="Biotoscana International"/><FilterOption id="15742" count="11" label="Dong-A ST Co Ltd"/><FilterOption id="1038227" count="11" label="Ensysce Biosciences Inc"/><FilterOption id="17259" count="11" label="Ipsen"/><FilterOption id="17392" count="11" label="Janssen-Cilag Ltd"/><FilterOption id="1093663" count="11" label="Knight Therapeutics Inc"/><FilterOption id="18090" count="11" label="Merck Sharp &amp; Dohme Ltd"/><FilterOption id="18614" count="11" label="Novo Nordisk A/S"/><FilterOption id="16299" count="11" label="Sanofi Genzyme"/><FilterOption id="18053" count="11" label="The Menarini Group"/><FilterOption id="1005244" count="10" label="Biogen Inc"/><FilterOption id="1089706" count="10" label="Endo International plc"/><FilterOption id="17900" count="10" label="H Lundbeck A/S"/><FilterOption id="26997" count="10" label="Janssen Biotech Inc"/><FilterOption id="20519" count="9" label="National Cancer Institute"/><FilterOption id="1040956" count="9" label="RaQualia Pharma Inc"/><FilterOption id="28921" count="9" label="Swedish Orphan Biovitrum AB"/><FilterOption id="18720" count="9" label="Taiho Pharmaceutical Co Ltd"/><FilterOption id="17736" count="8" label="Altus Formulation Inc"/><FilterOption id="19687" count="8" label="Bayer Schering Pharma AG"/><FilterOption id="14557" count="8" label="Bayer Yakuhin Ltd"/><FilterOption id="15358" count="8" label="Cephalon Inc"/><FilterOption id="16583" count="8" label="GC Pharma"/><FilterOption id="1053335" count="8" label="Horizon Pharma plc"/><FilterOption id="15411" count="8" label="JW Pharmaceutical Corp"/><FilterOption id="17665" count="8" label="Kissei Pharmaceutical Co Ltd"/><FilterOption id="18552" count="8" label="Nippon Shinyaku Co Ltd"/><FilterOption id="24154" count="8" label="Recordati SpA"/><FilterOption id="19214" count="8" label="Regeneron Pharmaceuticals Inc"/><FilterOption id="1002503" count="8" label="Takeda Pharmaceuticals International GmbH"/><FilterOption id="29387" count="7" label="Dr Reddy's Laboratories Ltd"/><FilterOption id="29708" count="7" label="Ferring Pharmaceuticals SA"/><FilterOption id="16611" count="7" label="Hanmi Pharmaceutical Co Ltd"/><FilterOption id="1022379" count="7" label="Hikma Pharmaceuticals plc"/><FilterOption id="1033982" count="7" label="Insys Therapeutics Inc"/><FilterOption id="29943" count="7" label="Medison Pharma Ltd"/><FilterOption id="24019" count="7" label="MSD Japan"/><FilterOption id="15713" count="7" label="Nuvo Pharmaceuticals Inc"/><FilterOption id="DOL1000087" count="7" label="Orient Europharma"/><FilterOption id="1017117" count="7" label="Sumitomo Dainippon Pharma Co Ltd"/><FilterOption id="25218" count="6" label="Aventis Pharma AG"/><FilterOption id="25861" count="6" label="BioMarin Pharmaceutical Inc"/><FilterOption id="15410" count="6" label="Chong Kun Dang Pharmaceutical Corp"/><FilterOption id="29213" count="6" label="Elite Pharmaceuticals Inc"/><FilterOption id="17633" count="6" label="Kaken Pharmaceutical Co Ltd"/><FilterOption id="1038304" count="6" label="KemPharm Inc"/><FilterOption id="16074" count="6" label="Laboratorios Dr Esteve SA"/><FilterOption id="1023179" count="6" label="Lee's Pharmaceutical Holdings Limited"/><FilterOption id="21932" count="6" label="Lupin Ltd"/><FilterOption id="1085756" count="6" label="Mallinckrodt plc"/><FilterOption id="18049" count="6" label="Meiji Seika Pharma Co Ltd"/><FilterOption id="24191" count="6" label="Purdue Pharma LP"/><FilterOption id="1043338" count="6" label="Recro Pharma Inc"/><FilterOption id="24643" count="6" label="Salix Pharmaceuticals Ltd"/><FilterOption id="1050515" count="6" label="ViiV Healthcare Ltd"/><FilterOption id="1153354" count="5" label="Alfasigma SpA"/><FilterOption id="14233" count="5" label="Angelini Pharmaceuticals SpA"/></Filter><Filter label="Highest Phase" name="phaseHighest" total="13"><FilterOption id="NDR" count="1965" label="No Development Reported"/><FilterOption id="L" count="1081" label="Launched"/><FilterOption id="DX" count="906" label="Discontinued"/><FilterOption id="DR" count="655" label="Discovery"/><FilterOption id="C2" count="426" label="Phase 2 Clinical"/><FilterOption id="C3" count="226" label="Phase 3 Clinical"/><FilterOption id="C1" count="173" label="Phase 1 Clinical"/><FilterOption id="PR" count="50" label="Pre-registration"/><FilterOption id="R" count="36" label="Registered"/><FilterOption id="CU" count="30" label="Clinical"/><FilterOption id="W" count="26" label="Withdrawn"/><FilterOption id="S" count="10" label="Suspended"/><FilterOption id="OL" count="1" label="Outlicensed"/></Filter></Filters></drugResultsOutput>